DXR PE Ratio & Valuation,Is DXR Overvalued

DXR Relative Valuation

DXR's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, DXR is overvalued; if below, it's undervalued.

Historical Valuation

Daxor Corp (DXR) is now in the Overvalued zone, suggesting that its current forward PS ratio of 604.55 is considered Overvalued compared with the five-year average of 15.82. The fair price of Daxor Corp (DXR) is between 1.32 to 8.28 according to relative valuation methord. Compared to the current price of 12.25 USD , Daxor Corp is Overvalued By 47.89%.

Relative Value

Fair Zone

1.32-8.28

Current Price：12.25

47.89%

Overvalued

2.45

0.00

EV/EBITDA

Daxor Corp. (DXR) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is 12.51. The thresholds are as follows: Strongly Undervalued below -35.73, Undervalued between -35.73 and -11.61, Fairly Valued between 36.63 and -11.61, Overvalued between 36.63 and 60.75, and Strongly Overvalued above 60.75. The current Forward EV/EBITDA of 0.00 falls within the Historic Trend Line -Fairly Valued range.

0.00

EV/EBIT

Daxor Corp. (DXR) has a current EV/EBIT of 0.00. The 5-year average EV/EBIT is 5.94. The thresholds are as follows: Strongly Undervalued below -17.49, Undervalued between -17.49 and -5.77, Fairly Valued between 17.65 and -5.77, Overvalued between 17.65 and 29.36, and Strongly Overvalued above 29.36. The current Forward EV/EBIT of 0.00 falls within the Historic Trend Line -Fairly Valued range.

604.55

Daxor Corp. (DXR) has a current PS of 604.55. The 5-year average PS is 252.60. The thresholds are as follows: Strongly Undervalued below -177.24, Undervalued between -177.24 and 37.68, Fairly Valued between 467.52 and 37.68, Overvalued between 467.52 and 682.43, and Strongly Overvalued above 682.43. The current Forward PS of 604.55 falls within the Overvalued range.

0.00

P/OCF

Daxor Corp. (DXR) has a current P/OCF of 0.00. The 5-year average P/OCF is -6.91. The thresholds are as follows: Strongly Undervalued below -34.12, Undervalued between -34.12 and -20.51, Fairly Valued between 6.70 and -20.51, Overvalued between 6.70 and 20.30, and Strongly Overvalued above 20.30. The current Forward P/OCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.

0.00

P/FCF

Daxor Corp. (DXR) has a current P/FCF of 0.00. The 5-year average P/FCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/FCF of 0.00 falls within the Strongly Undervalued range.

Daxor Corp (DXR) has a current Price-to-Book (P/B) ratio of 1.71. Compared to its 3-year average P/B ratio of 1.37 , the current P/B ratio is approximately 24.83% higher. Relative to its 5-year average P/B ratio of 1.84, the current P/B ratio is about -7.09% higher. Daxor Corp (DXR) has a Forward Free Cash Flow (FCF) yield of approximately 2.27%. Compared to its 3-year average FCF yield of -3.45%, the current FCF yield is approximately -165.84% lower. Relative to its 5-year average FCF yield of -4.04% , the current FCF yield is about -156.20% lower.

1.71

P/B

Median3y

1.37

Median5y

1.84

2.27

FCF Yield

Median3y

-3.45

Median5y

-4.04

Competitors Valuation Multiple

The average P/S ratio for DXR's competitors is 151.14, providing a benchmark for relative valuation. Daxor Corp Corp (DXR) exhibits a P/S ratio of 604.55, which is 300% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

Revenue Growth

Market Cap

Performance Decomposition

Market capitalization of DXR increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00%to the performance.

Overall, the performance of DXR in the past 1 year is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is Daxor Corp (DXR) currently overvalued or undervalued?

What is Daxor Corp (DXR) fair value?

DXR's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Daxor Corp (DXR) is between 1.32 to 8.28 according to relative valuation methord.

How does DXR's valuation metrics compare to the industry average?

The average P/S ratio for DXR's competitors is 151.14, providing a benchmark for relative valuation. Daxor Corp Corp (DXR) exhibits a P/S ratio of 604.55, which is 300.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

What is the current P/B ratio for Daxor Corp (DXR) as of Dec 15 2025?

As of Dec 15 2025, Daxor Corp (DXR) has a P/B ratio of 1.71. This indicates that the market values DXR at 1.71 times its book value.

What is the current FCF Yield for Daxor Corp (DXR) as of Dec 15 2025?

As of Dec 15 2025, Daxor Corp (DXR) has a FCF Yield of 2.27%. This means that for every dollar of Daxor Corp’s market capitalization, the company generates 2.27 cents in free cash flow.

What is the current Forward P/E ratio for Daxor Corp (DXR) as of Dec 15 2025?

As of Dec 15 2025, Daxor Corp (DXR) has a Forward P/E ratio of 2.45. This means the market is willing to pay $2.45 for every dollar of Daxor Corp’s expected earnings over the next 12 months.

What is the current Forward P/S ratio for Daxor Corp (DXR) as of Dec 15 2025?

As of Dec 15 2025, Daxor Corp (DXR) has a Forward P/S ratio of 604.55. This means the market is valuing DXR at $604.55 for every dollar of expected revenue over the next 12 months.

DXR Valuation

DXR Valuation

DXR Relative Valuation

Historical Valuation

Competitors Valuation Multiple

Performance Decomposition

People Also Watch

Frequently Asked Questions

Is Daxor Corp (DXR) currently overvalued or undervalued?

What is Daxor Corp (DXR) fair value?

How does DXR's valuation metrics compare to the industry average?

What is the current P/B ratio for Daxor Corp (DXR) as of Dec 15 2025?

What is the current FCF Yield for Daxor Corp (DXR) as of Dec 15 2025?

What is the current Forward P/E ratio for Daxor Corp (DXR) as of Dec 15 2025?

What is the current Forward P/S ratio for Daxor Corp (DXR) as of Dec 15 2025?